ETHZ
ETHZ
NASDAQ · Biotechnology

Ethzilla Corp

$2.89
-0.09 (-3.02%)
As of Apr 1, 3:25 PM ET ·
Financial Highlights (FY 2025)
Revenue
35.77M
Net Income
-8,575,403
Gross Margin
54.2%
Profit Margin
-24.0%
Rev Growth
+23.1%
D/E Ratio
0.47
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 54.2% 54.2% 54.2%
Operating Margin -24.4% -26.0% -27.0%
Profit Margin -24.0% -25.5% -20.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 35.77M 36.63M 30.48M
Gross Profit 19.38M 19.85M 16.52M
Operating Income -8,719,693 -9,508,920 -8,236,314
Net Income -8,575,403 -9,331,208 -6,103,234
Gross Margin 54.2% 54.2% 54.2%
Operating Margin -24.4% -26.0% -27.0%
Profit Margin -24.0% -25.5% -20.0%
Rev Growth +23.1% +18.9% +13.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 11.79M 11.84M 10.20M
Total Equity 24.92M 25.85M 26.81M
D/E Ratio 0.47 0.46 0.38
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -11,561,063 -12,252,085 -10,099,093
Free Cash Flow -5,624,875 -5,815,077 -3,826,455